Updated Oct 18
Related News
Feb 15, 2026
DOGE Unleashes the Largest Medicaid Dataset: Elon Musk's Transparency "State of Mind"!
The Department of Government Efficiency (DOGE) has made a groundbreaking move by open-sourcing the largest Medicaid dataset in its history. Touted by Elon Musk as a transformative transparency initiative, this release includes aggregated provider-level claims data from 2018 to 2024. Designed to enable fraud detection on an unprecedented scale, the data covers fee-for-service, managed care, and more. Early analyses have already flagged $90 billion in potential fraud, showcasing the dataset's game-changing potential for healthcare oversight.
DOGEMedicaidElon Musk
Feb 14, 2026
Elon Musk's DOGE Team Unveils Groundbreaking Medicaid Dataset to Combat Fraud
In a bid to enhance public oversight, Elon Musk's Department of Government Efficiency (DOGE) has unveiled a massive Medicaid dataset, covering claims and payments from 2018 to 2024. This bold release aims to expose fraud in the system, aligning with recent Republican arguments for major Medicaid funding cuts. However, critics argue it's a smokescreen for reducing essential services.
Elon MuskMedicaidDOGE
Nov 15, 2025
Trump Administration Strikes Major Deal with Pharma Giants: Ozempic Prices Slashed!
In an unprecedented move, President Trump has announced a landmark deal with Novo Nordisk and Eli Lilly to significantly reduce the prices of popular GLP-1 medications, including Ozempic and Wegovy. These drugs, crucial for diabetes and obesity treatment, will see slashed prices for Medicare, Medicaid, and cash-paying patients, all part of the new TrumpRx initiative aimed at broadening access and alleviating drug costs. The deal reflects a pivotal shift in U.S. healthcare policy with far-reaching implications for patients and the pharmaceutical industry.
TrumpRxGLP-1 medicationsOzempic